252 related articles for article (PubMed ID: 32431053)
21. Prevalence of ALK gene alterations among the spectrum of plexiform spitzoid lesions.
Saraggi D; Salmaso R; Zamuner C; Munari G; Lanza C; Alaibac MS; Bassetto F; Rugge M; Montesco MC; Cerroni L; Fassan M
J Am Acad Dermatol; 2018 Oct; 79(4):728-735. PubMed ID: 29920315
[TBL] [Abstract][Full Text] [Related]
22. Spitz nevus and atypical spitzoid neoplasm.
Miteva M; Lazova R
Semin Cutan Med Surg; 2010 Sep; 29(3):165-73. PubMed ID: 21051010
[TBL] [Abstract][Full Text] [Related]
23. Clinical and pathologic findings of Spitz nevi and atypical Spitz tumors with ALK fusions.
Busam KJ; Kutzner H; Cerroni L; Wiesner T
Am J Surg Pathol; 2014 Jul; 38(7):925-33. PubMed ID: 24698967
[TBL] [Abstract][Full Text] [Related]
24. Classification of Indeterminate Melanocytic Lesions by MicroRNA Profiling.
Latchana N; Del Campo SE; Grignol VP; Clark JR; Albert SP; Zhang J; Wei L; Aldrink JH; Nicol KK; Ranalli MA; Peters SB; Gru A; Trihka P; Payne PR; Howard JH; Carson WE
Ann Surg Oncol; 2017 Feb; 24(2):347-354. PubMed ID: 27469124
[TBL] [Abstract][Full Text] [Related]
25. Expanding spectrum of "spitzoid" lesions: a small series of 4 cases with MAP2K1 mutations.
Kerckhoffs KGP; Aallali T; Ambarus CA; Sigurdsson V; Jansen AML; Blokx WAM
Virchows Arch; 2021 Jul; 479(1):195-202. PubMed ID: 33040161
[TBL] [Abstract][Full Text] [Related]
26. TRPM1 (Melastatin-1/MLSN1) mRNA expression in Spitz nevi and nodular melanomas.
Erickson LA; Letts GA; Shah SM; Shackelton JB; Duncan LM
Mod Pathol; 2009 Jul; 22(7):969-76. PubMed ID: 19396153
[TBL] [Abstract][Full Text] [Related]
27. Atypical Spitz Tumors: A Diagnostic Challenge.
Harms KL; Lowe L; Fullen DR; Harms PW
Arch Pathol Lab Med; 2015 Oct; 139(10):1263-70. PubMed ID: 26414472
[TBL] [Abstract][Full Text] [Related]
28. Integrative histopathological and immunophenotypical characterisation of the inflammatory microenvironment in spitzoid melanocytic neoplasms.
Hillen LM; Vandyck HLD; Leunissen DJG; de Greef BTA; Bosisio FM; Zur Hausen A; van den Oord J; Winnepenninckx V
Histopathology; 2021 Mar; 78(4):607-626. PubMed ID: 32970867
[TBL] [Abstract][Full Text] [Related]
29. A Clinicopathological Study of 29 Spitzoid Melanocytic Lesions With ALK Fusions, Including Novel Fusion Variants, Accompanied by Fluorescence In Situ Hybridization Analysis for Chromosomal Copy Number Changes, and Both TERT Promoter and Next-Generation Sequencing Mutation Analysis.
Kastnerova L; Martinek P; Grossmann P; Steiner P; Vanecek T; Kyclova J; Ferak I; Zalud R; Slehobr O; Svajdler P; Sulc M; Bradamante M; Banik M; Hadravsky L; Sticova E; Hajkova V; Ptakova N; Michal M; Kazakov DV
Am J Dermatopathol; 2020 Aug; 42(8):578-592. PubMed ID: 32701692
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics associated with Spitz nevi and Spitzoid malignant melanomas: the Yale University Spitzoid Neoplasm Repository experience, 1991 to 2008.
Lott JP; Wititsuwannakul J; Lee JJ; Ariyan S; Narayan D; Kluger HH; Lazova R
J Am Acad Dermatol; 2014 Dec; 71(6):1077-82. PubMed ID: 25308882
[TBL] [Abstract][Full Text] [Related]
31. Melanocytic nevi with Spitz differentiation: diagnosis and management.
Ahmadi N; Davison SP; Kauffman CL
Laryngoscope; 2010 Dec; 120(12):2385-90. PubMed ID: 21072755
[TBL] [Abstract][Full Text] [Related]
32. Spitz nevi, atypical spitzoid neoplasms, and spitzoid melanoma.
Zedek DC; McCalmont TH
Clin Lab Med; 2011 Jun; 31(2):311-20. PubMed ID: 21549244
[TBL] [Abstract][Full Text] [Related]
33. Spitz Tumors With ROS1 Fusions: A Clinicopathological Study of 6 Cases, Including FISH for Chromosomal Copy Number Alterations and Mutation Analysis Using Next-Generation Sequencing.
Donati M; Kastnerova L; Martinek P; Grossmann P; Sticová E; Hadravský L; Torday T; Kyclova J; Michal M; Kazakov DV
Am J Dermatopathol; 2020 Feb; 42(2):92-102. PubMed ID: 31361613
[TBL] [Abstract][Full Text] [Related]
34. Utility of p16-Ki-67-HMB45 score in sorting benign from malignant Spitz tumors.
Garola R; Singh V
Pathol Res Pract; 2019 Oct; 215(10):152550. PubMed ID: 31351802
[TBL] [Abstract][Full Text] [Related]
35. The Spitzoid lesion: rethinking Spitz tumors, atypical variants, 'Spitzoid melanoma' and risk assessment.
Barnhill RL
Mod Pathol; 2006 Feb; 19 Suppl 2():S21-33. PubMed ID: 16446713
[TBL] [Abstract][Full Text] [Related]
36. Oncogenic BRAF and the tumor suppressor IGFBP7 in the genesis of atypical spitzoid nevomelanocytic proliferations.
Emley A; Yang S; Wajapeyee N; Green MR; Mahalingam M
J Cutan Pathol; 2010 Mar; 37(3):344-9. PubMed ID: 19788444
[TBL] [Abstract][Full Text] [Related]
37. An update on molecular alterations in melanocytic tumors with emphasis on Spitzoid lesions.
Dimonitsas E; Liakea A; Sakellariou S; Thymara I; Giannopoulos A; Stratigos A; Soura E; Saetta A; Korkolopoulou P
Ann Transl Med; 2018 Jun; 6(12):249. PubMed ID: 30069451
[TBL] [Abstract][Full Text] [Related]
38. A Diagnostic Algorithm Combining Immunohistochemistry and Molecular Cytogenetics to Diagnose Challenging Melanocytic Tumors.
Redon S; Guibourg B; Talagas M; Marcorelles P; Uguen A
Appl Immunohistochem Mol Morphol; 2018; 26(10):714-720. PubMed ID: 28362709
[TBL] [Abstract][Full Text] [Related]
39. Spitz nevi and Spitzoid melanomas: exome sequencing and comparison with conventional melanocytic nevi and melanomas.
Lazova R; Pornputtapong N; Halaban R; Bosenberg M; Bai Y; Chai H; Krauthammer M
Mod Pathol; 2017 May; 30(5):640-649. PubMed ID: 28186096
[TBL] [Abstract][Full Text] [Related]
40. Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome.
Barnhill RL; Argenyi ZB; From L; Glass LF; Maize JC; Mihm MC; Rabkin MS; Ronan SG; White WL; Piepkorn M
Hum Pathol; 1999 May; 30(5):513-20. PubMed ID: 10333219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
